Dr. Faisal  Imam
My Social Links

Dr. Faisal Imam

Assistant Professor
King Saud University, Saudi Arabia


Highest Degree
Ph.D. in Clinical Pharmacy from Jamia Hamdard, India

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Molecular Biology
62%
Biochemical Studies
90%
Oxidative Stress
75%
Clinical Pharmacy
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Imam, F., N.O. Al-Harbi, M.M. Al-Harbi, W. Qamar and K. Aljerian et al., 2019. Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries. Int. immunopharmacol., 66: 260-266.
    CrossRef  |  Direct Link  |  
  2. Ansari, M.N., R.I. Aloliet, M.A. Ganaie, T.H. Khan, Najeeb-ur-Rehman, F. Imam and A.M. Hamad, 2019. Roflumilast, a phosphodiesterase 4 inhibitor, attenuates cadmium-induced renal toxicity via modulation of NF-κB activation and induction of NQO1 in rats. Hum. Exp. Toxicol., 38: 588-597.
    CrossRef  |  Direct Link  |  
  3. Ansari, M.N., M.A. Ganaie, N.U. Rehman, K.M. Alharthy and T.H. Khan et al., 2019. Protective role of Roflumilast against cadmium-induced cardiotoxicity through inhibition of oxidative stress and NF-κB signaling in rats. Saudi Pharm. J., 27: 673-681.
    CrossRef  |  Direct Link  |  
  4. Al-Harbi, N.O., F. Imam, M.M. Al-Harbi, O.A. Al-Shabanah and M.R. Alotaibi et al., 2019. Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway. Inflammopharmacology, 27: 817-827.
    CrossRef  |  Direct Link  |  
  5. Imam, F., N.O. Al-Harbi, M.M. Al-Harbi, M.A. Ansari and A.F. Al-Asmari et al., 2018. Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways. Pharmacol. Rep., 70: 993-1000.
    CrossRef  |  Direct Link  |  
  6. Alshahrani, S.M., A.S. Alshetaili, A. Alalaiwe, B.B. Alsulays and M.K. Anwer et al., 2018. Anticancer efficacy of self-nanoemulsifying drug delivery system of sunitinib malate. AAPS Pharm. Sci. Tech., 19: 123-133.
    Direct Link  |  
  7. Imam, F., N.O. Al-Harbi, M.M. Al-Harbia, H.M. Korashy and M.A. Ansari et al., 2017. Rutin attenuates carfilzomib-induced cardiotoxicity through inhibition of NF-κB, hypertrophic gene expression and oxidative stress. Cardiovasc. Toxicol., 17: 58-66.
    CrossRef  |  PubMed  |  Direct Link  |  
  8. Alanazi, A., S.G. Algfeley, K.A. Al‐Hosaini, H.M. Korashy and F. Imam et al., 2017. Therapeutic potential of carfilzomib, an irreversible proteasome inhibitor, against acetaminophen‐induced hepatotoxicity in mice. J. Biochem. Mol. Toxicol., Vol. 31. 10.1002/jbt.21877.
    CrossRef  |  Direct Link  |  
  9. Korashy, H.M., M.A. Ansari, Z.H. Maayah, F. Imam and M. Raish et al., 2016. Differential effects of sunitinib on the expression profiles of xenobiotic-metabolizing enzymes and transporters in rat liver and Kidneys. Basic. Clin. Pharmacol. Toxicol., 119: 73-83.
  10. Iqbal, M., E. Ezzeldin, S.T. Al-Rashood, F. Imam and K.A. Al-Rashood, 2016. Determination of apremilast in rat plasma by UPLC–MS/MS in ESI-negative mode to avoid adduct ions formation. Bioanalysis, 8: 1499-1508.
    CrossRef  |  Direct Link  |  
  11. Imam, F., N.O. Al-Harbi, M.M. Al-Harbi, M.A. Ansari and M.M. Almutairi et al., 2016. Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats. Toxicol. Mech. Methods, 26: 700-708.
    CrossRef  |  Direct Link  |  
  12. Bakheet, S.A., A.M. Alhuraishi, N.O. Al‐Harbi, K.A. Al‐Hosaini and S.D. Al‐Sharary et al., 2016. Alleviation of aflatoxin B1‐induced genomic damage by proanthocyanidins via modulation of DNA repair. J. Biochem. Mol. Toxicol., 30: 559-566.
    CrossRef  |  Direct Link  |  
  13. Khayyam, U.K., S. Muzammil, M. Yunus and F. Imam, 2015. Epidemiological study of obesity in urban population based on body mass index. J. Sci. Pharm., 5: 196-200.
  14. Iqbal, M., N.Y. Khalil, F. Imam, M.K. Anwer, 2015. A validated high-throughput UHPLC-MS/MS assay for accurate determination of rivaroxaban in plasma sample. J. Thromb Thrombolysis, 39: 79-88.
    CrossRef  |  Direct Link  |  
  15. Imam, F., N.O. Al-Harbi, M.M. Al-Harbi, M.A. Ansari and K.M.A. Zoheir et al., 2015. Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice. Pharmacol. Res., 102: 1-11.
    CrossRef  |  Direct Link  |  
  16. Bhat, M.A., M.A. Al-Omar, M.A. Ansari, K.M.A. Zoheir and F. Imam et al., 2015. Design and synthesis of N-arylphthalimides as inhibitors of glucocorticoid-induced TNF receptor-related protein, proinflammatory mediators, and cytokines in carrageenan-induced lung inflammation. J. Med. Chem. 58: 8850-8867.
    CrossRef  |  Direct Link  |  
  17. Al-Harbi, N.O., F. Imam, A. Nadeem, M.M. Al-Harbi and H.M. Korashy et al., 2015. Riboflavin attenuates lipopolysaccharide-induced lung injury in rats. Toxicol. Mech. Methods, 25: 417-423.
    CrossRef  |  
  18. Al-Harbi, N.O., A. Nadeem, M.M. Al-Harbi, F. Imam and O.A. Al-Shabanah et al., 2015. Oxidative airway inflammation leads to systemic and vascular oxidative stress in a murine model of allergic asthma. Int. Immunopharmacol., 26: 237-245.
    CrossRef  |  Direct Link  |  
  19. Nadeem, A., N. Siddiqui, N.O. Alharbi, M.M. Alharbi, F. Imam and M.M. Sayed-Ahmed, 2014. Glutathione modulation during sensitization as well as challenge phase regulates airway reactivity and inflammation in mouse model of allergic asthma. Biochimie., 103: 61-71.
    CrossRef  |  PubMed  |  
  20. Nadeem, A., N. Siddiqui, N.O. Alharbi, M.M. Alharbi and F. Imam, 2014. Acute glutathione depletion leads to enhancement of airway reactivity and inflammation via p38MAPK-iNOS pathway in allergic mice. Int. Immunopharmacol., 22 : 222-229.
    CrossRef  |  Direct Link  |  
  21. Al-Harbi, N.O., F. Imam, M.M. Al-Harbi, M. Iqbal and A. Nadeem et al., 2014. Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. Biomed. Res. Int., Vol. 2014. 10.1155/2014/607246.
    CrossRef  |  
  22. Al-Harbi, N.O., F. Imam, M.M. Al-Harbi, M. Iqbal and A Nadeem et al., 2014. Treatment with aliskiren ameliorates tacrolimus-induced nephrotoxicity in rats. J. Renin Angiotensin Aldosterone Syst., 16: 1329-1336.
    CrossRef  |  Direct Link  |  
  23. Al-Harbi, N.O., F. Imam, A. Nadeem, M.M. Al-Harbi and M. Iqbal et al., 2014. Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren. Toxicology Mech. Meth., 24: 697-702.
    CrossRef  |  Direct Link  |  
  24. Al-Harbi, N.O., F. Imam, A. Nadeem, M.M. Al-Harbi and M. Iqbal et al., 2014. Carbon tetrachloride-induced hepatotoxicity in rat is reversed by treatment with riboflavin. Int. Immunopharmacol., 21: 383-388.
    CrossRef  |  Direct Link  |  
  25. Saleem, S., M.A. Shaharyar, M.J. Khusroo, P. Ahmad and R.U. Rahman et al., 2013. Anticancer potential of rhamnocitrin 4′-β-d-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol. Cell. Biochem., 384: 147-153.
    CrossRef  |  Direct Link  |  
  26. Kazmi, I., M. Afzal, S. Rahman, M. Iqbal, F. Imam and F. Anwar, 2013. Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase. Eur. J. pharmacol., 709: 28-36.
    CrossRef  |  Direct Link  |  
  27. Afzal, M., I. Kazmi, R. Khan, R. Singh and M. Pravez et al., 2013. Pharmacological evaluation of gatifloxacin in chemically Induced hepatocarcinogenesis: A new tool for hepato-cellularcarcinoma treatment. J. Cancer Sci. Ther., 5: 18-22.
    CrossRef  |  
  28. Munsab, A., S. Manju, A.K. Najmi, I. Faisal, M. Santanu and K.M. Ravinder, 2012. Associated socioeconomic status with illness behavior in tuberculosis patients undergoing DOTS therapy. Indian J. Pharm. Pract., 5: 45-48.
    Direct Link  |  
  29. Ali, M.S., M.S. Alam, F.I. Imam and M.R. Siddiqui, 2012. Topical nanoemulsion of turmeric oil for psoriasis: Characterization, ex vivo and in vivo assessment. Int. J. Drug Delivery, 4: 184-197.
    CrossRef  |  
  30. Alam, M.S., M.S. Ali, N. Alam, M.I. Alam, T. Anwer, F. Imam and M. Shamim, 2012. Design and characterization of nanostructure topical gel of betamethasone dipropionate for psoriasis. J. Applied Pharm. Sci., 2: 148-158.
    CrossRef  |  Direct Link  |  
  31. Afzal, M., G. Gupta, I. Kazmi, M. Rahman and G. Upadhyay et al., 2012. Evaluation of anxiolytic activity of embelin isolated from Embelia ribes. Biomed. Aging Pathol., 2: 45-47.
    CrossRef  |  
  32. Khayyam, U.K., S. Muzammil and F. Imam, 2011. Distribution of obesity among male and female population based on body mass index and relative body weight. J. Hosp. Clin. Pharmacy., 1: 1-7.
  33. Ansari, M.S., K.U. Khayyam, M. Sharma, F. Imam and D. Behera, 2011. The role of socio-economic factors responsible for non-compliance of directly observed treatment short-course among tuberculosis patients. J. Med. Health Sci., 18: 78-86.
    Direct Link  |  
  34. Khayyam, K.U., F. Imam, M. Sharma, K.K. Pillai and D. Behera, 2010. Pyrazinamide-induced maculopapular rash. Indian J. Dermatol., 55: 384-386.
    Direct Link  |  
  35. Imam, F., M.K. Anwer, M. Iqbal, S. Alam, K.U. Khayyam and M. Sharma, 2010. Tuberculosis: Brief overview and its shifting paradigm for management in India. Int. J. Pharmacol., 6: 755-783.
    CrossRef  |  Direct Link  |  
  36. Anwer, T., M. Sharma, M. Iqbal, F. Imam and K.K. Pillai, 2009. Comparative analysis of the protective effects of melatonin and silymarin on lipid peroxidation and dyslipidemia in STZ-induced diabetic rats. Hamdard Medicus., 52: 58-61.
  37. Sharma, M., Z.R. Ashraf, K.K. Pillai, D Ahmad and F. Imam, 2008. Protective effect of alpha-ketoglutarate on heart against doxorubicin induced cardiotoxicity in rats. Indian J. Pharmacol., 40: 166-166.
  38. Sharma, M., K.U. Khayyam, V. Kumar, F. Imam, K.K. Pillai and D. Behera, 2008. Influence of honey on adverse reactions due to anti-tuberculosis drugs in pulmonary tuberculosis patients. Continental J. Pharmacol. Toxicol. Res., 2: 6-11.
    Direct Link  |  
  39. Sharma, H., M. Aqil, F. Imam, M.S. Alam, P. Kapur and K.K. Pillai, 2007. A pharmacovigilance study in the department of medicine of a university teaching hospital. Pharmacy Pract., 5: 46-49.
    Direct Link  |  
  40. Aqil, M., F. Imam, A. Hussain, M.S. Alam, P. Kapur and K.K. Pillai, 2006. A pharmacovigilance study for monitoring adverse drug reactions with antihypertensive agents at a South Delhi hospital. Int. J. Pham. Pract., 14: 311-313.
    CrossRef  |  Direct Link  |